Subcellular localisation of cyclin B, Cdc2 and p21 WAF1/CIP1 in breast cancer - association with prognosis

By Winters Z.E.   Hunt N.C.   Bradburn M.J.   Royds J.A.   Turley H.   Harris A.L.   Norbury C.J.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2405-2412

Elsevier

Access to resources Recommend Favorite

Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

By Grillo Mary   Bott Matthew   Khandke Neha   McGinnis John   Miranda Miriam   Meyyappan Muthupalaniappan   Rosfjord Edward   Rabindran Sridhar  

Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. : 185-194

Springer Publishing Company

Access to resources Recommend Favorite

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

By Ahnström Marie  

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 145-151

Springer Publishing Company

Access to resources Recommend Favorite

Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved

By Terzoudi G. I.   Jung T.   Hain J.   Vrouvas J.   Margaritis K.   Donta-Bakoyianni C.   Makropoulos V.   Angelakis Ph.   Pantelias G. E.  

International Journal of Radiation Biology, Vol. 76, Iss. 5, 2000-05 ,pp. : 607-615

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Human Breast Cancer Cell Growth by Blockade of the Mevalonate-Protein Prenylation Pathway is not Prevented by Overexpression of Cyclin D1

By Germano D.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 1, 2001-05 ,pp. : 23-33

Springer Publishing Company

Access to resources Recommend Favorite